Sharp Heerenveen, The Netherlands

Sharp’s Heerenveen facility provides both large-scale and specialised small-batch packaging capacity in shared or dedicated production suites. We offer expertise and capabilities in multiple specialist formats, and enables access to the EU market through in-house QP services.

Our facility also offers a complete range of specialized cold chain packaging and labelling services for gene therapy products. A specialist infrastructure is in place including temperature and humidity controls and monitoring, and full -80°C freezer banks in shared or dedicated packaging suites.

Sharp Heerenveen holds also a European clinical services depot offering distribution and QP release services for investigational medicinal products (IMPs) in conjunction with our site in Rhymney, UK.

Facility Highlights

8,500 m² (92,100 ft²) facility including GMP production space, warehouse and offices
Ambient and refrigerated (2-8°C) packaging, storage, and distribution
Frozen (-80°C) storage and distribution
Shared and dedicated production areas
Controlled drug management
Manufacturing License for Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP)
Electronic Batch Record (EBR) generated via our Manufacturing Execution Systems (MES)
Gene therapy small-batch cold chain packaging suite
- Optimal environment and specialist infrastructure
- Dedicated HVAC air handling
- Temperature and humidity controls and monitoring
- Full -80°C freezer banks in dedicated production suites